Protective immunity in experimental Candida vaginitis

Research in Immunology

Volumn 149, Issue 4-5, 1998, Pages 361-373

  Fidel Jr , P L ^a   Sobel, J D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A;

CELL POPULATION; DISEASE PREDISPOSITION; HOST RESISTANCE; HYPOTHESIS; IMMUNITY; INFECTION RISK; MYCOSIS; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REVIEW; SPECIES DIFFERENCE; VAGINA CANDIDIASIS; VAGINITIS;

EID: 0032079214     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(98)80760-8     Document Type: Article

References (78)

1. Arancia, G., Molinari, A., Crateri, P., Stringaro, A., Ramoni, C., Dupuis, M.L., Gomez, M.J., Torosantucci, A. & Cassone, A. (1995), Noninhibitory binding of human interleukin-2-activated natural killer cells to the germ tube forms of Candida albicans. Infect. Immun., 63, 280-288.
2. Balish, E., Filutowicz, H. & Oberley, T.D. (1990), Correlates of cell-mediated immunity in Candida albicans-colonized gnotobiotic mice. Infect. Immun., 58, 107-113.
3. Bennett, J.E. (1990), Antimicrobial agents: antifungal agents. In Goodman and Gilman's, the pharmacological basis of therapeutics (eds A.G. Gilman, T.W. Rall, A.S. Nies & P. Taylor), pp. 1165-1181. Pergamon Press, Inc., Elmsford, N.Y.
4. Bistoni, F., Cenci, E., Mencacci, A., Schiaffelia, E., Mosci, P., Puccetti, P. & Romani, L. (1993), Mucosal and systemic T helper cell function after intragastric colonization of adult mice with Candida albicans. J. Infect. Dis., 168, 1449-1457.
5. Black, C.A., Eyers, F.M., Russell, A., Dunkley, M.L., Clancy, R.L. & Beagley, K.W. (1998), Acute neutropenia in inflammation is associated with murine vaginal candidiasis but has no effect on the course of infection. Infect. Immun., 66, 1273-1275.
6. Cain, T.K. & Rank, R.G. (1995), Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect. Immun., 63(5), 1784-1789.
7. Cantorna, M.T. & Balish, E. (1990a), Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect. Immun., 58, 1093-1100.
8. Cantorna, M.T., Mook, D. & Balish, E. (1990b), Resistance of congenitally immunodeficient gnotobiotic mice to vaginal candidasis. Infect. Immun., 58, 3813-3815.
9. Casadevall, A. (1995), Antibody immunity and invasive fungal infections. Infect. Immun., 63, 4211-4218.
10. Cassone, A., Boccanera, M., Adriani, D.A., Santoni, G. & De Bernardis, F. (1995), Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal infection. Infect. Immun., 63, 2619-2624.
11. Clark, R.A., Blakley, S.A., Rice, J. & Brandon, W. (1995), Predictors of HIV progression in women. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 9, 43-50.
12. Clift, R.A. (1984), Candidiasis in the transplant patient. American Journal of Medicine, 77 (suppl. 4D), 34-38.
13. De Bernardis, F., Boccanera, M., Adriana, D., Spreghini, E., Santoni, G. & Cassone, A. (1997), Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect. Immun., 65, 3399-3405.
14. Djeu, J.Y. & Blanchard, D.K. (1987), Regulation of human polymorphonuclear neutrophil (PMN) activity against Candida albicans by large granular lymphocytes via release of a PMN-activating factor. J. Immunol., 139, 2761-2767.
15. Ehrensaft, D.V., Epstien, R.B., Sarpel, S. & Andersen, B.R. (1979), Disseminated candidias in leukopenic dogs. Proc. Soc. Exp. Biol. Med., 160, 6-10.
16. Elin, R.J., Edelin, J.B. & Wolff, S.M. (1974), Infection and immunoglobulin concentrations in Chediak-Higashi mice. Infect. Immun., 10, 88-91.
17. Ferrante, A. & Thong, Y.H. (1979), Requirement of heat-labile opsonins for maximal phagocytosis of Candida albicans. Sabouraudia, 17, 293-297.
18. Fidel, P.L., Jr., Luo, W., Chabain, J., Wolf, N.A. & Van Buren, E. (1997), Use of cellular depletion analysis to examine circulation of immune effector function between the vagina and the periphery. Infect. Immun., 65, 3939-3943.
19. Fidel, P.L., Jr., Lynch, M.E. & Sobel, J.D. (1993), Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis. Infect. Immun., 61, 1990-1995.
20. Fidel, P.L., Jr., Lynch, M.E. & Sobel, J.D. (1994), Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis. Infect. Immun., 62, 1032-1038.
21. Fidel, P.L., Jr., Cutright, J.L. & Sobel, J.D. (1995), Effects of systemic cell-mediated immunity on vaginal candidiasis in mice resistant and susceptible to Candida albicans infections. Infect. Immun., 63, 4191-4194.
22. Fidel, P.L., Jr., Ginsburg, K.A., Cutright, J.L., Wolf, N.A., Leaman, D., Dunlap, K. & Sobel, J.D. (1997), Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen. J. Infect. Dis., 176, 728-739.
23. Fidel, P.L., Jr., Luo, W., Steele, C., Chabain, J. & Wormley, F. (1998), Analysis of vaginal cell populations during experimental C. albicans vaginitis. ASM Annual Meeting (Abstract).
24. Fidel, P.L., Jr., Lynch, M.E., Conaway, D.H., Tait, L. & Sobel, J.D. (1995a), Mice immunized by primary vaginal C. albicans infection develop acquired vaginal mucosal immunity. Infect. Immun., 63, 547-553.
25. Fidel, P.L., Jr., Lynch, M.E., Redondo-Lopez, V., Sobel, J.D. & Robinson, R. (1993a), Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis (RVVC). J. Infect. Dis., 168, 1458-1465.
26. Fidel, P.L., Jr., Lynch, M.E. & Sobel, J.D. (1993b), Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis. Infect. Immun., 61, 4202-4207.
27. Fidel, P.L., Jr., Lynch, M.E. & Sobel, J.D. (1995b), Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis. Infect. Immun., 63 , 2403-2408.
28. Fidel, P.L., Jr., Wolf, N.A., Cutright, J.L., Sobel, J.D. & Schuman, P. (1996a), Canada-specific Th1/Th2 reactivity in HIV+ women. ASM Conference on Candida and Candidiasis (Abstract).
29. Fidel, P.L., Jr., Wolf, N.A. & Kukuruga, M.A. (1996b), T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the periphery. Infect. Immun., 3793-3799.
30. Fratti, R.A., Ghannoum, M.A., Edwards, J.E., Jr. & Filler, S.G. (1996), Gamma interferon protects endothelial cells from damage by Candida albicans by inhibiting endothelial cell phagocytosis. Infect. Immun., 64, 4714-4718.
31. Han, Y. & Cutler, J.E. (1995), Antibody response that protects against disseminated candidiasis. Infect. Immun., 63, 2714-2719.
32. Hector, R.F., Domer, J.E. & Carrow, E.W. (1982), Immune responses to Candida albicans in genetically distinct mice. Infect. Immun., 38, 1020-1028.
33. Hedges, S.R., Agace, W.W. & Svanborg, C. (1995), Epithelial cytokine responses and mucosal cytokine networks. Trends Microbiol., 3, 266-270.
34. Holm, H.W. & Marwin, R.M. (1967), Effects of surface active agents on the susceptibility of Swiss mice to Candida albicans. Mycopathol. Mycol. Appl., 33, 186-192.
35. + αβ T cells of the murine female genital tract: a phenotypically distinct T cell lineage that rapidly proliferates in response to systemic T cell activation stimuli. Int. Immunol., 7, 1763-1769.
36. Imam, N., Carpenter, C.C.J., Mayer, K.H., Fisher, A., Stein, M. & Danforth, S.B. (1990), Hierarchical pattern of mucosal Candida infections in HIV-seropositive women. Am. J. Med., 89, 142-146.
37. Itohara, S., Farr, A.G., Lafaille, J.J., Bonneville, M., Takagaki, Y., Haas, W. & Tonegawa, S. (1990), Homing of a gamma/delta thymocyte subset with homogenous T-cell receptors to mucosal epithelia. Nature, 343, 754-757.
38. Jones-Carson, J., Vazquez-Torres, A., Van der Heyde, Warner, T., Wagner, R.D. & Balish, E. (1995), γ/δ T cell-induced nitric oxide production enhances resistance to mucosal candidiasis. Nature Med., 6, 552-557.
39. Kagaya, K. & Fukazawa, Y. (1981), Murine defense mechanism against Candida albicans infection. II. Opsonization, phagocytosis and intracellular killing of Candida albicans. Microbiol. Immunol., 25, 807-818.
40. Kaufmann, S.H.E. (1990), Heat shock proteins and the immune response. Immunol. Today, 114, 129-136.
41. Kelly, K.A. & Rank, R.G. (1997), Identification of homing receptors that mediate the recruitment of CD4 T cells to the genital tract following intravaginal infection with Chlamydia trachomatis. Infect. Immun., 65, 5198-5208.
42. Kent, H.L. (1991), Epidemiology of vaginitis. Am. J. Obstet. Gynecol., 165, 1168-1175.
43. Kinsman, O.S. & Collard, A.E. (1986), Hormonal factors in vaginal candidiasis in rats. Infect. Immun., 53, 498-504.
44. Kirkpatrick, C.H. (1989), Chronic mucocutaneous candidiasis. Eur. J. Clin. Microbiol. Infect. Dis., 8 , 448-456.
45. Kirkpatrick, C.H., Rich, R.R. & Bennett, J.E. (1971), Chronic mucocutaneous candidiasis: model building in cellular immunity. Ann. Intern. Med., 75, 955-978.
46. Klein, R.S., Harris, C.A., Small, C.B. & et al. (1984), Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N. Engl. J. Med., 311, 354-357.
47. Klink, M., Rozalaska, B. & Rudnicka, W. (1993), Weakness of cellular response to Listeria antigens in pregnant mice [Polish]. Medycyna Doswiadczalna i Mikrobiologia, 45(1), 51-54.
48. Knight, L. & Fletcher, J. (1971), Growth of Candida albicans in saliva: stimulation by glucose associated with antibiotics, corticosteriods and diabetes mellitus. J. Infect. Dis., 123, 371-377.
49. Liljemark, W.F. & Gibbons, R.J. (1973), Suppression of Candida albicans by human oral streptococci in gnotobiotic mice. Infect. Immun., 8, 846-849.
50. Lynch, M.E., Sobel, J.D. & Fidel, P.L., Jr. (1996), Role of antifingal drug resistance in the pathogenesis of recurrent vulvovaginal candidasis. J. Med. Vet. Mycol., 34, 337-339.
51. Macher, A.M. (1988), The pathology of AIDS. Public Health Report, 103, 246-250.
52. Mathur, S., Mathur, R.S., Goust, J.M., Williamson, H.O. & Fundenberg, H.H. (1979), Cyclic variations in white cell subpopulations in the human menstrual cycle: correlations with progesterone and estradiol. Clin. Immunol. Immunopathol., 13, 246-253.
53. Mathur, S., Virella, G., Koistinen, J., Horger, E.O., Mahvi, T.A. & Fudenberg, H.H. (1977), Humoral immunity in vaginal candidiasis. Infect. Immun., 15, 287-294.
54. Matthews, R.C., Burnie, J.P., Howat, D., Rowland, T. & Walton, F. (1991), Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis. Immunology, 74 , 20-24.
55. Matthews, R.C., Burnie, J.P. & Tabaqchali, S. (1984), Immunoblot analysis of the serological response in systemic candidosis. Lancet, 2, 1415-1418.
56. Mazumder, D.N., Ghose, N., Mirta, J., Dutta, G. & Santra, A. (1990), Immunological status of women with prolonged oral contraceptives and occurrence of giardiasis. J. Indian Med. Assoc., 88(5), 129-131.
57. Nandi, D. & Allison, J.P. (1991), Phenotypic analysis and gamma/delta-T cell receptor repertoire of murine T cells associated with the vaginal epithelium. J. Immunol., 147, 1773-1778.
58. Odds, F.C. (1988), Chronic mucocutaneous candidiosis. In Candida and candidosis pp. 104-110. University Park Press, Baltimore, MD.
59. Ozenci, H., Scott, M., Luo, W. & Fidel, P.L., Jr. (1997), Growth inhibition of Candida albicans by vaginal cells from naive mice. American Society for Microbiology, Annual Meeting, Abstract F-107.
60. Parr, M.B., Kepple, L. & Parr, E.L. (1991), Antigen recognition in the female reproductive tract. H. Endocytosis of horseradish peroxidase by Langerhans cells in murine vaginal epithelium. Biology Reprod., 45, 261-265.
61. Parr, M.B. & Parr, E.L. (1990), Antigen recognition in the female reproductive tract. I. Uptake of intraluminal protein tracers in the mouse vagina. J. Reprod. Immunol., 17, 101-114.
62. Parr, M.B. & Parr, E.L. (1991), Langerhans cells and T lymphocyte subsets in the murine vagina and cervix. Biology Reprod., 44, 491-498.
63. Paterson, P.Y., Semo, R., Blumenschein, G. & Swelstad, J. (1971), Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy. Clin. Exp. Immunol., 9, 595-602.
64. Polonelli, L., De Bernardis, F., Conti, S., Boccanera, M., Gerloni, M., Morace, G., Magliani, W., Chezzi, C. & Cassone, A. (1994), Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory yeast killer toxin-like anti-idiotypic antibodies. J. Immunol., 152, 3175-3182.
65. Polonelli, L., De Bernardis, F., Conti, S., Boccanera, M., Magliani, W., Gerloni, M., Cantella, C. & Cassone, A. (1996), Human natural yeast killer toxin-like candidicidal antibodies. J. Immunol., 156, 1880-1885.
66. Rhoads, J.L., Wright, D.C., Redfield, R.R. & Burke, D.S. (1987), Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA, 257, 3105-3107.
67. Rogers, T.J. & Balish, E. (1980), Immunity to Candida albicans. Microbiol. Rev., 44, 660-682.
68. Romani, L., Mencacci, A., Cenci, E., Spaccapelo, R., Mosci, P., Puccetti, P. & Bistoni, F. (1993), CD+ subset expression in murine candidiasis. J. Immunol., 150, 925-931.
69. Romani, L., Mocci, S., Bietta, C., Lanfaloni, L., Puccetti, P. & Bistoni, F. (1991), Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. Infect. Immun., 59, 4647-4654.
70. Ryley, J.F. & McGregor, S. (1986), Quantitation of vaginal Candida albicans infections in rodents. J. Med. Vet. Mycol., 24, 455-460.
71. Sobel, J.D. (1988), Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann. N.Y. Acad. Sci., 544, 547-557.
72. Sobel, J.D. (1992), Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin. Inf. Dis., 14, S148-S153.
73. Steele, C., Ratterree, M., Harrison, R. & Fidel, P.L., Jr., (1998), Differential susceptibility to experimental vaginal candidiasis in macaques. ASM Annual Meeting (Abstract).
74. Valentin, A., Bernard, C., Mallie, M., Huerre, M. & Bastide, J.M. (1993), Control of Candida albicans vaginitis in mice by short-duration butoconazole treatment in situ. Mycoses, 36, 379-384.
75. White, M.H. (1996), Is vulvovaginal candidiasis an AIDS-related illness. Clin. Inf. Dis., 22 (Suppl. 2), S124-S127.
76. Witkin, S.S. (1991), Immunologic factors influencing susceptibility to recurrent candidal vaginitis. Clin. Obstet. Gynecol., 34, 662-668.
77. + T cells. AAI Annual Meeting (Abstract).
78. Yamamura, M. & Valdimarsson, H. (1977), Participation of C3 in intracellular of Candida albicans. Scand. J. Immunol., 6, 591-594.